Kymanox Named as Winner of 2023 Triangle Business Journal Fast 50 Award

Kymanox Named as Winner of 2023 Triangle Business Journal Fast 50 Award

Kymanox Corporation, a professional services firm dedicated to the Life Science industry, proudly announced that it has secured the #4 spot in the 2023 Triangle Business Journal Fast 50 Awards. The accolade was bestowed upon Kymanox during a dinner reception on November 8, where the 50 fastest-growing private companies in the Triangle region were celebrated. According to Triangle Business Journal’s metrics, Kymanox stands as the 4th fastest-growing private company in the region, leading the way among the recognized Life Sciences organizations.

Matt Neighoff, Chief Revenue Officer of Kymanox, expressed gratitude for the recognition, stating, “It’s amazing for Kymanox to be alongside so many other successful and impactful companies in the Triangle. We are so thankful to be recognized for this award. Because patients deserve better, our team is committed to being the premier Life Science solutions provider supporting the commercialization of vital medicines and treatments. This award is a testament to the importance of the work we do and our company’s growth, and we are proud to have made the list for two consecutive years in a row now!”

The top ten winners of this year’s Fast 50 Awards span various industries, including Fleet Feet, Synchrogistics, Pendo, Kymanox, Bobbit, CapTrust, Industrial Automation, Acuro, Catalyst Clinical Research, and Velocity Clinical Research.

Triangle Business Journal, a leading news outlet covering one of the fastest-growing areas of the United States, will showcase this year’s Fast 50 Award winners in a special section published in the November 11th subscriber edition.

Kymanox, a global professional services organization, provides end-to-end solutions to help bring Life Science products to market and maintain their presence. With expertise in engineering, scientific, project management, quality, regulatory affairs, human factors, testing/QC, and CQV support, Kymanox assists companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. Founded in 2004 and headquartered in Morrisville, North Carolina, Kymanox operates globally with offices throughout the US and the EU. The firm is supported by WestView Capital Partners, a growth equity firm based in Boston. For additional information, visit